{"schemaVersion":1,"profileUrl":"https://nowen.ai/agents/otl-stanford-edu","markdownUrl":"https://nowen.ai/agents/otl-stanford-edu.md","jsonUrl":"https://nowen.ai/agents/otl-stanford-edu.json","name":"Stanford University","nickname":"Stanford","website":"https://otl.stanford.edu","industry":"Academic Institutions","status":{"trust":"unclaimed","text":"Unclaimed: compiled by Nowen from public sources, not reviewed by the company"},"updatedAt":"2026-09-06T23:47:12.318Z","summary":"Stanford University is a leading research institution that commercializes innovations through its Office of Technology Licensing and the High Impact Technology Fund.","description":"Stanford University is a premier research institution that translates early-stage discoveries into real-world impact through technology licensing and strategic funding. The Office of Technology Licensing supports researchers, startups, and industry partners by identifying, protecting, and commercializing innovations. Through programs such as the High Impact Technology (HIT) Fund, Stanford accelerates collaboration across Life Sciences, Physical Sciences, and Sustainability to advance health, environmental, and societal outcomes. The organization serves academic researchers, entrepreneurs, corporate partners, and investors, providing pathways to licensing, partnerships, and funding to scale technologies from laboratory to market.","mission":"To translate Stanford research into real-world benefits by licensing technologies, forming partnerships, and supporting high-impact research through targeted funding programs.","directory":{"industryName":"Academic Institutions","agentCount":8,"indexable":false,"hubUrl":"https://nowen.ai/industry/academic-institutions"},"aiReaderFamilies":["Amazon"],"products":[{"name":"Christa Biologics","type":"Product","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/christa-biologics","summary":"Improves heart function through mitochondrial transplantation therapy.","description":"Mitochondrial transplantation therapy for heart failure.","pricing":{},"features":[{"name":"Mitochondrial transplantation","value":"Enhances Heart Function","valueDescription":"This innovative therapy improves heart function by restoring energy levels in damaged heart cells, providing a potential remedy for heart failure."}]},{"name":"DesRhex","type":"Product","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/desrhex-corneal-endothelial","summary":"Revolutionizes corneal transplantation by enhancing surgical precision.","description":"Corneal endothelial transplant surgical device.","pricing":{},"features":[{"name":"Endothelial Corneal Transplant Device","value":"Enables Efficient Surgical Procedures","valueDescription":"This device allows for safer and more efficient surgical procedures during endothelial corneal transplants, ultimately improving patient outcomes."},{"name":"Improved Surgical Precision","value":"Enhances Surgical Accuracy","valueDescription":"Utilizing state-of-the-art calibration and design, this device significantly improves the accuracy of corneal placement, reducing the risks associated with transplantation."}]},{"name":"Exhalos","type":"Product","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/exhalos-breath-testing","summary":"Enables early detection of necrotizing enterocolitis through non-invasive breath testing.","description":"Breath testing for necrotizing enterocolitis.","pricing":{},"features":[{"name":"Breath Testing for NEC","value":"Facilitates Early Diagnosis","valueDescription":"The Exhalos breath test provides a safe and effective method for identifying necrotizing enterocolitis in infants, allowing for timely intervention and improved patient outcomes."}]},{"name":"Immunera","type":"Platform","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/immunera-precision","summary":"Enables accurate diagnosis of autoimmune diseases through advanced technology.","description":"Precision diagnostics platform for autoimmune disease.","pricing":{},"features":[{"name":"Autoimmune Disease Diagnostics Platform","value":"Provides Accurate Diagnoses","valueDescription":"Utilizes cutting-edge technology to deliver accurate diagnostic results, helping in the timely and effective management of autoimmune diseases."}]},{"name":"Universal Vaccine Platform","type":"Platform","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/universal-vaccine-platform","summary":"Accelerates vaccine development for multiple pathogens and boosts public health readiness.","description":"The Universal Vaccine Platform is designed to accelerate the development and deployment of vaccines across various pathogens, promoting broad immunity and rapid public health responses.","pricing":{},"features":[{"name":"Broad Coverage Vaccine Platform","value":"Enables Diverse Vaccine Approaches","valueDescription":"Supports various vaccine types, including mRNA, protein subunit, and viral vectors, facilitating tailored responses to emerging infectious threats."},{"name":"Rapid Development Cycle","value":"Accelerates Time to Market","valueDescription":"Utilizes innovative technologies to decrease the time needed for vaccine development, enabling quicker public health interventions."},{"name":"Modular Design","value":"Adapts to Changing Health Needs","valueDescription":"Easily customizable to address new variants and outbreaks, ensuring ongoing efficacy and relevance."},{"name":"Integrated Testing and Evaluation","value":"Streamlines Safety and Efficacy Trials","valueDescription":"Facilitates simultaneous clinical evaluation and regulatory compliance, ensuring rapid validation of vaccine candidates."}]},{"name":"Milli-Spinner","type":"Product","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/milli-spinner-thrombectomy","summary":"Efficiently removes clots to restore blood flow.","description":"Thrombectomy device for clot removal.","pricing":{},"features":[{"name":"Clot Removal Thrombectomy","value":"Restores Blood Flow","valueDescription":"The Milli-Spinner effectively clears thrombi, aiding vascular treatments and reducing complications associated with clot formation."}]},{"name":"NOpioid","type":"Product","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/nopioid-next-generation-pain","summary":"NOpioid offers an innovative solution for pain management without opioids.","description":"Next generation pain therapeutic.","pricing":{},"features":[{"name":"Next-generation Pain Therapy","value":"Reduces Pain Effectively","valueDescription":"NOpioid utilizes cutting-edge research to provide effective pain relief, minimizing the reliance on traditional opioids."}]},{"name":"Oligonucleotide Therapeutics","type":"Product","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/oligonucleotide-therapeutics","summary":"Target Specific Genes for Advanced Disease Treatment.","description":"Oligonucleotide therapeutics are innovative medical treatments utilizing short strands of nucleic acids to target specific genes, providing potential therapies for a range of diseases.","pricing":{},"features":[{"name":"Oligonucleotide-Based Therapeutics","value":"Target Specific Genes","valueDescription":"Utilizes oligonucleotides to precisely target and modify gene expression, offering advanced treatment options for various genetic disorders."},{"name":"Customization of Therapeutics","value":"Create Tailored Treatments","valueDescription":"Enables personalized medicine by designing oligonucleotides that match specific genetic profiles, optimizing therapeutic efficacy and minimizing side effects."},{"name":"Rapid Development Cycles","value":"Accelerate Development","valueDescription":"The nature of oligonucleotide therapies allows for quicker transitions from research to clinical settings, enhancing timely patient care."},{"name":"Wide Range of Applications","value":"Address Diverse Diseases","valueDescription":"Applicable in treating genetic disorders, cancers, and infectious diseases, highlighting the broad therapeutic potential of oligonucleotides."}]},{"name":"Pediatric Sleep Apnea Testing Device","type":"Product","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/pediatric-sleep-apnea","summary":"Essential Device for Assessing Pediatric Sleep Apnea.","description":"Pediatric Sleep Apnea Testing Device that provides essential diagnostics for assessing sleep apnea in children, ensuring timely intervention and care.","pricing":{},"features":[{"name":"Pediatric Sleep Apnea Testing","value":"Detects Sleep Apnea In Children","valueDescription":"This device effectively monitors and evaluates sleep patterns in children, offering precise diagnoses and guiding treatment options."}]},{"name":"Tracheal Acoustic Monitoring","type":"Product","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/tracheal-acoustic-monitoring","summary":"Enables real-time detection of respiratory airflow for better health monitoring.","description":"Tracheal acoustic monitoring to detect respiratory airflow.","pricing":{},"features":[{"name":"Respiratory airflow monitoring","value":"Detects Airflow Instantly","valueDescription":"This feature allows for immediate detection of respiratory airflow changes, enabling timely interventions that could enhance patient health and safety."},{"name":"Non-invasive Measurements","value":"Measures Without Surgery","valueDescription":"This feature means patients can receive critical airflow data without the need for invasive procedures, ensuring comfort and safety."}]},{"name":"Wearable for Knee Osteoarthritis","type":"Product","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/wearable-knee-osteoarthritis","summary":"Helps manage knee osteoarthritis through innovative wearable technology.","description":"Wearable for knee osteoarthritis.","pricing":{},"features":[{"name":"Knee Osteoarthritis Wearable","value":"Assists In Managing Pain","valueDescription":"This device provides targeted support for individuals with knee osteoarthritis, helping to alleviate pain and improve mobility."},{"name":"Real-Time Monitoring","value":"Enables Personalized Feedback","valueDescription":"The device continuously monitors knee performance and offers real-time feedback to enhance user experience and rehabilitation."},{"name":"User-Friendly Interface","value":"Simplifies User Interaction","valueDescription":"The interface is intuitive, allowing users to easily track their progress and manage their condition without technical complications."}]},{"name":"Haptica Robotics","type":"Platform","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/haptica-robotics","summary":"Enables efficient training of robots through remote operation.","description":"Teleoperation platform for robot training.","pricing":{},"features":[{"name":"Teleoperation Platform","value":"Enhances Training Efficiency","valueDescription":"By allowing users to remotely control robots, the platform significantly enhances training efficiency and effectiveness, allowing for diverse and practical training scenarios."},{"name":"Real-Time Control","value":"Facilitates Immediate Corrections","valueDescription":"The platform allows trainers to make immediate corrections during sessions, thereby improving learning outcomes and skill acquisition for robots."},{"name":"User-Friendly Interface","value":"Simplifies Operation","valueDescription":"The interface is designed to simplify operations, making it accessible for users with varying levels of expertise."}]},{"name":"Photonic Routers for Solid-State Imaging","type":"Product","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/photonic-routers-solid","summary":"Enhances solid-state imaging systems through advanced routing of photonic signals.","description":"Photonic routers for solid-state imaging.","pricing":{},"features":[{"name":"Photonic Routers","value":"Enable Efficient Signal Routing","valueDescription":"These routers facilitate the efficient routing of photonic signals, improving the overall performance and capabilities of solid-state imaging systems, enabling faster data processing and enhanced imaging resolution."}]},{"name":"Nanoscale Lithography","type":"Product","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/nanoscale-lithography","summary":"Enables Precise Nanoscale Patterning For Advanced Applications.","description":"Nanoscale Lithography facilitates precise patterning at the nanoscale, enabling advanced applications in fields such as electronics, photonics, and biomedicine. This innovative technology supports the fabrication of intricate structures essential for next-generation devices.","pricing":{},"features":[{"name":"Nanoscale Patterning Capability","value":"Achieves High-Resolution Designs","valueDescription":"This capability allows for the creation of intricate nanoscale patterns essential for the development of cutting-edge devices in electronics, photonics, and biomedicine."}]},{"name":"Immersive Virtual Acoustic Spaces","type":"Platform","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/Immersive-virtual-acoustic-spaces","summary":"Create Realistic Audio Environments For Enhanced User Experiences.","description":"Immersive virtual acoustic spaces enable the creation and exploration of realistic audio environments, enhancing user experiences across various applications.","pricing":{},"features":[{"name":"Immersive Acoustic Spaces","value":"Facilitates Engaging Audio Environments","valueDescription":"This feature allows users to craft detailed and interactive audio settings, enhancing user immersion through realistic soundscapes."},{"name":"Real-time Audio Interaction","value":"Enables Dynamic Audio Adjustments","valueDescription":"Users can interact with the virtual environment, leading to immediate audio modifications that respond to their actions, creating a seamless and fluid experience."},{"name":"Cross-Platform Compatibility","value":"Increases Accessibility Across Devices","valueDescription":"Users can access the immersive acoustic spaces on different devices, expanding usability and user engagement."}]},{"name":"Magnefy","type":"Platform","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/magnefy-predictive","summary":"Enhances operational efficiency through predictive maintenance for power assets.","description":"Magnefy: Predictive maintenance solutions for critical power assets.","pricing":{},"features":[{"name":"Predictive Maintenance for Power Assets","value":"Optimize Maintenance Scheduling","valueDescription":"Allows for timely interventions to prevent failures, ensuring operational continuity and reducing downtime."},{"name":"Data-Driven Insights","value":"Enhance Decision-Making","valueDescription":"Empowers users with actionable insights for smarter operational decisions, resulting in cost savings and performance improvements."},{"name":"User-Friendly Interface","value":"Streamline User Access","valueDescription":"Facilitates easier interaction with complex data, making it accessible for all users regardless of technical background."}]},{"name":"Kerra","type":"Platform","url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23sustainability/kerra-keratin-based","summary":"Sustainable alternative to fossil fuels using keratin technology.","description":"Keratin-Based Platform to Replace Fossil-Fuel Materials.","pricing":{},"features":[{"name":"Keratin-based platform","value":"Reduces Fossil Fuel Dependency","valueDescription":"By leveraging keratin as a bio-based material, this platform minimizes reliance on fossil fuels, promoting a more sustainable and eco-friendly approach to material production."},{"name":"Sustainability Focus","value":"Enhances Environmental Responsibility","valueDescription":"Contributes to environmental sustainability by providing an alternative to conventional, petroleum-based materials."}]}],"audiences":[],"segments":[{"name":"Surgical and interventional devices","description":"Devices for surgical and catheter-based interventions to repair or replace tissue and remove vascular obstructions.","size":60,"cagr":6,"color":1,"productNames":["DesRhex","Milli-Spinner"],"methodology":"Estimate derived by reconciling submarket figures in the provided search results: interventional cardiology devices (~USD 31.1B in 2026, CAGR 6.4%), minimally invasive devices (~USD 46.6B in 2024, CAGR ~4.4%), and powered surgical instruments (~USD 2.52B in 2026, CAGR 4.7%). To avoid double-counting (overlap between minimally invasive and interventional cardiology), the midpoint aggregation yields an approximate global surgical & interventional devices market of ~USD 60B (circa 2025–2026). Growth potential (CAGR ~6.0%) reflects the higher-growth interventional cardiology segment and broader medical-devices market trend (overall medical devices CAGR ~6.9%), balanced against slower segments in powered instruments and minimally invasive devices.","citations":[{"url":"https://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html","text":"Global interventional cardiology devices market projected at USD 31.12 billion in 2026; CAGR 6.4% (2026-2031)."},{"url":"https://www.coherentmarketinsights.com/market-insight/powered-surgical-instruments-market-803","text":"Global powered surgical instruments market estimated at USD 2.52 Bn in 2026; CAGR 4.7% (2026-2033)."},{"url":"https://www.marketresearchfuture.com/reports/minimally-invasive-devices-market-43705","text":"Minimally invasive devices market: 2024 size USD 46.58B; CAGR 4.43% (2025-2035)."},{"url":"https://www.fortunebusinessinsights.com/industry-reports/medical-devices-market-100085","text":"Global medical devices market valued at USD 572.31 billion in 2025; CAGR 6.9% (2026–2034)."}]},{"name":"Remote patient monitoring","description":"Capabilities that collect, visualize, and act on continuous biometric and patient-reported data to support at-home monitoring and clinician-led interventions.","size":28.6,"cagr":11.2,"color":2,"productNames":["Exhalos","Immunera","Pediatric Sleep Apnea Testing Device","Tracheal Acoustic Monitoring","Wearable for Knee Osteoarthritis"],"methodology":"Estimates use multiple market reports in the search results. Global specialist reports cluster around mid-to-high $20–30B in the mid-2020s (GMI, MarketiQuest/LinkedIn). GMI reports USD 26.2B (2025) and USD 28.6B (2026) with 11.2% CAGR; MarketsandMarkets reports the US RPM market at USD 16.09B (2025) with a 12.6% US CAGR, indicating regional variance. Fortune Business Insights provides a higher 2025 estimate (USD 59.92B) and a higher CAGR (19.16%), representing a broader/alternative sizing. I selected a consensus global market size near USD 28.6B and a growth potential of ~11.2% CAGR reflecting corroborating sources.","citations":[{"url":"https://www.gminsights.com/industry-analysis/remote-patient-monitoring-devices-market","text":"The remote patient monitoring devices market size was valued at USD 26.2 billion in 2025."},{"url":"https://www.marketsandmarkets.com/Market-Reports/us-remote-patient-monitoring-rpm-market-252862303.html","text":"The US RPM market stood at US$16.09 billion in 2025 and is projected to US$29.13 billion by 2030, CAGR 12.6% (2025-2030)."},{"url":"https://www.fortunebusinessinsights.com/remote-patient-monitoring-devices-market-106328","text":"The global remote patient monitoring devices market size was valued at USD 59.92 billion in 2025."},{"url":"https://www.linkedin.com/pulse/global-remote-patient-monitoring-market-size-share-wp0cf","text":"Market value: $28.56 Bn in 2024; forecast CAGR: 11.2%."}]},{"name":"Biopharmaceutical platforms and therapeutics","description":"Therapeutic platforms and next‑generation biologics including oligonucleotide therapies, universal vaccine platforms, and cell‑based treatments.","size":155,"cagr":12.5,"color":3,"productNames":["Oligonucleotide Therapeutics","Universal Vaccine Platform","Christa Biologics","NOpioid"],"methodology":"Estimated current (platforms & next‑gen biologics) market size by applying a 25–30% share to published global biopharmaceutical market values (SNS Insider, Precedence/ BioSpace, MarketDataForecast). SNS reports USD 486.15B (2023) and Precedence reports USD 537.54B (2025); applying ~30% yields ~146–161B and midpoint ≈155B. Growth CAGR set higher than broad biopharma because oligonucleotides, cell therapies and vaccine platforms are higher‑growth subsegments; supported by higher subsegment/platform CAGRs (drug discovery/platforms CAGR ~13.7% and Precedence biopharma CAGR 14.36%). A conservative blended CAGR of 12.5% reflects faster growth than legacy biologics but below the highest single forecast.","citations":[{"url":"https://www.snsinsider.com/reports/biopharmaceutical-market-4184","text":"The Biopharmaceutical Market Size was valued at USD 486.15 Billion in 2023 ... grow at a CAGR of 8.82%."},{"url":"https://www.biospace.com/press-releases/biopharmaceuticals-market-size-expected-to-reach-usd-1-796-21-bn-by-2034","text":"The global biopharmaceuticals market size is evaluated at USD 537.54 billion in 2025 ... growing at a CAGR of 14.36% from 2025 to 2034."},{"url":"https://www.marketdataforecast.com/market-reports/bio-pharmaceuticals-market","text":"The global biopharmaceuticals market was valued at USD 250.50 billion in 2024 ... growing at a CAGR of 9.2% from 2025 to 2033."},{"url":"https://www.coherentmarketinsights.com/industry-reports/drug-discovery-platforms-market","text":"The global drug discovery platforms market is estimated to be valued at USD 240.2 Mn in 2026 ... CAGR of 13.7% from 2026 to 2033."}]},{"name":"Advanced photonics and nanoscale fabrication","description":"Photonics and nanoscale patterning technologies for imaging, sensing, and micro/nanofabrication in electronics, photonics, and biomedical devices.","size":300,"cagr":7.5,"color":4,"productNames":["Nanoscale Lithography","Photonic Routers for Solid-State Imaging"],"methodology":"Estimated by anchoring to published global photonics market figures (~USD 1.05–1.09 trillion in 2025) and the advanced-optics submarket (~USD 287B in 2023). Advanced photonics/nanoscale fabrication (imaging, sensing, PICs, micro/nanofabrication) is treated as a material subset of the larger photonics market (roughly 25–35%), supplemented by a small but fast-growing nanopatterning market (~USD 2.95B in 2025). Weighted the dominant photonics growth (≈6.3–6.7% from industry reports) with higher-growth niches (advanced optics ≈9.2% and nanopatterning ≈14.6%) to derive a combined CAGR ~7.5%.","citations":[{"url":"https://www.fortunebusinessinsights.com/photonics-market-106525","text":"The global photonics market size was valued at USD 1,049.50 billion in 2025"},{"url":"https://www.marketsandmarkets.com/Market-Reports/photonics-market-88194993.html","text":"the photonics market was valued at USD 1,094 billion in 2025 (projected) and growing at 6.3% cagr"},{"url":"https://pureon.com/advanced-optics-market-insight-2025/","text":"In 2023, the global advanced optics market was valued at approximately USD 287.29 billion (projected to 2032, CAGR 9.2%)"},{"url":"https://www.snsinsider.com/reports/nanopatterning-market-9871","text":"The Nanopatterning Market size was valued at USD 2.95 Billion in 2025 (CAGR 14.63% during 2026–2035)"}]},{"name":"Industrial automation and control systems","description":"Integration of robotics, conveyors, custom machinery, UL-certified control panels and SCADA for production automation, real-time monitoring, and process optimization.","size":275,"cagr":9.6,"color":5,"productNames":["Haptica Robotics","Magnefy"],"methodology":"Multiple market reports in the provided results converge on a ~USD 272–275 billion market size in 2025 and project high single-digit to ~10% CAGRs into the early 2030s. MarketsandMarkets reports USD 274.99B (2025) with a 9.6% CAGR to 2030; Fortune Business Insights reports USD 272.51B (2025) and ~9.8% mid-term CAGR; Coherent Market Insights gives a lower 2026 base but a similar high-single-digit CAGR (9.2%) to 2033. AlixPartners and others forecast the overall automation market surpassing USD 400B by 2030, supporting continued ~9–10% growth. I therefore estimate a current market size ≈ USD 275B and growth potential ~9.6% CAGR.","citations":[{"url":"https://www.marketsandmarkets.com/Market-Reports/factory-industrial-automation-sme-smb-market-541.html","text":"Market Size in 2025 (Value) USD 274.99 Billion; CAGR of 9.6% (2025-2030)."},{"url":"https://www.fortunebusinessinsights.com/industry-reports/industrial-automation-market-101589","text":"The global industrial automation market size was estimated at USD 272.51 billion in 2025."},{"url":"https://www.coherentmarketinsights.com/market-insight/industrial-automation-and-control-systems-market-5917","text":"Market is estimated to be valued at USD 226.44 Bn in 2026; expected to reach USD 419.28 Bn in 2033; CAGR of 9.2%."},{"url":"https://www.alixpartners.com/media/iljl3awg/alixpartners_industrial-automation-market_january-2025.pdf","text":"Overall market size to surpass $400 billion by 2030."}]}],"faq":[],"comparisons":[],"sources":[{"url":"https://otl.stanford.edu","text":"Stanford University"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/christa-biologics","text":"Christa Biologics"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/desrhex-corneal-endothelial","text":"DesRhex"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/exhalos-breath-testing","text":"Exhalos"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/immunera-precision","text":"Immunera"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/universal-vaccine-platform","text":"Universal Vaccine Platform"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/milli-spinner-thrombectomy","text":"Milli-Spinner"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/nopioid-next-generation-pain","text":"NOpioid"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/oligonucleotide-therapeutics","text":"Oligonucleotide Therapeutics"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/pediatric-sleep-apnea","text":"Pediatric Sleep Apnea Testing Device"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/tracheal-acoustic-monitoring","text":"Tracheal Acoustic Monitoring"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/wearable-knee-osteoarthritis","text":"Wearable for Knee Osteoarthritis"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/haptica-robotics","text":"Haptica Robotics"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/photonic-routers-solid","text":"Photonic Routers for Solid-State Imaging"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/nanoscale-lithography","text":"Nanoscale Lithography"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/Immersive-virtual-acoustic-spaces","text":"Immersive Virtual Acoustic Spaces"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/magnefy-predictive","text":"Magnefy"},{"url":"https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23sustainability/kerra-keratin-based","text":"Kerra"},{"url":"https://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html","text":"Global interventional cardiology devices market projected at USD 31.12 billion in 2026; CAGR 6.4% (2026-2031)."},{"url":"https://www.coherentmarketinsights.com/market-insight/powered-surgical-instruments-market-803","text":"Global powered surgical instruments market estimated at USD 2.52 Bn in 2026; CAGR 4.7% (2026-2033)."},{"url":"https://www.marketresearchfuture.com/reports/minimally-invasive-devices-market-43705","text":"Minimally invasive devices market: 2024 size USD 46.58B; CAGR 4.43% (2025-2035)."},{"url":"https://www.fortunebusinessinsights.com/industry-reports/medical-devices-market-100085","text":"Global medical devices market valued at USD 572.31 billion in 2025; CAGR 6.9% (2026–2034)."},{"url":"https://www.gminsights.com/industry-analysis/remote-patient-monitoring-devices-market","text":"The remote patient monitoring devices market size was valued at USD 26.2 billion in 2025."},{"url":"https://www.marketsandmarkets.com/Market-Reports/us-remote-patient-monitoring-rpm-market-252862303.html","text":"The US RPM market stood at US$16.09 billion in 2025 and is projected to US$29.13 billion by 2030, CAGR 12.6% (2025-2030)."},{"url":"https://www.fortunebusinessinsights.com/remote-patient-monitoring-devices-market-106328","text":"The global remote patient monitoring devices market size was valued at USD 59.92 billion in 2025."},{"url":"https://www.linkedin.com/pulse/global-remote-patient-monitoring-market-size-share-wp0cf","text":"Market value: $28.56 Bn in 2024; forecast CAGR: 11.2%."},{"url":"https://www.snsinsider.com/reports/biopharmaceutical-market-4184","text":"The Biopharmaceutical Market Size was valued at USD 486.15 Billion in 2023 ... grow at a CAGR of 8.82%."},{"url":"https://www.biospace.com/press-releases/biopharmaceuticals-market-size-expected-to-reach-usd-1-796-21-bn-by-2034","text":"The global biopharmaceuticals market size is evaluated at USD 537.54 billion in 2025 ... growing at a CAGR of 14.36% from 2025 to 2034."},{"url":"https://www.marketdataforecast.com/market-reports/bio-pharmaceuticals-market","text":"The global biopharmaceuticals market was valued at USD 250.50 billion in 2024 ... growing at a CAGR of 9.2% from 2025 to 2033."},{"url":"https://www.coherentmarketinsights.com/industry-reports/drug-discovery-platforms-market","text":"The global drug discovery platforms market is estimated to be valued at USD 240.2 Mn in 2026 ... CAGR of 13.7% from 2026 to 2033."},{"url":"https://www.fortunebusinessinsights.com/photonics-market-106525","text":"The global photonics market size was valued at USD 1,049.50 billion in 2025"},{"url":"https://www.marketsandmarkets.com/Market-Reports/photonics-market-88194993.html","text":"the photonics market was valued at USD 1,094 billion in 2025 (projected) and growing at 6.3% cagr"},{"url":"https://pureon.com/advanced-optics-market-insight-2025/","text":"In 2023, the global advanced optics market was valued at approximately USD 287.29 billion (projected to 2032, CAGR 9.2%)"},{"url":"https://www.snsinsider.com/reports/nanopatterning-market-9871","text":"The Nanopatterning Market size was valued at USD 2.95 Billion in 2025 (CAGR 14.63% during 2026–2035)"},{"url":"https://www.marketsandmarkets.com/Market-Reports/factory-industrial-automation-sme-smb-market-541.html","text":"Market Size in 2025 (Value) USD 274.99 Billion; CAGR of 9.6% (2025-2030)."},{"url":"https://www.fortunebusinessinsights.com/industry-reports/industrial-automation-market-101589","text":"The global industrial automation market size was estimated at USD 272.51 billion in 2025."},{"url":"https://www.coherentmarketinsights.com/market-insight/industrial-automation-and-control-systems-market-5917","text":"Market is estimated to be valued at USD 226.44 Bn in 2026; expected to reach USD 419.28 Bn in 2033; CAGR of 9.2%."},{"url":"https://www.alixpartners.com/media/iljl3awg/alixpartners_industrial-automation-market_january-2025.pdf","text":"Overall market size to surpass $400 billion by 2030."}]}